Reporting Clinical End Points and Safety Events in an Acute Coronary Syndrome Trial: Results With Integrated Collection

Reporting Clinical End Points and Safety Events in an Acute Coronary Syndrome Trial: Results With Integrated Collection

BackgroundEnd points and adverse events (AEs) are collected separately in clinical trials, yet regulatory requirements for serious AE reporting vary across regions, so classifying end points according to seriousness criteria can be useful in global trials. Methods and ResultsIn the Apixaban for Prev...

Full description

Bibliographic Details
Main Authors:	Patrícia O. Guimarães, Renato D. Lopes, Susanna R. Stevens, André Zimerman, Lisa Wruck, Stefan K. James, Ghazala Haque, Roberto Rocha C. V. Giraldez, John H. Alexander, Karen P. Alexander
Format:	Article
Language:	English
Published:	Wiley 2017-04-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	acute coronary syndrome clinical end points clinical events classification safety serious adverse events
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.117.005490

Similar Items

Effect of intensive versus standard blood pressure control on major adverse cardiac events and serious adverse events: A bivariate analysis of randomized controlled trials
by: Gerald Chi, et al.
Published: (2019-02-01)

Monitoring adverse social and medical events in public health trials: assessing predictors and interpretation against a proposed model of adverse event reporting
by: Gwenllian Moody, et al.
Published: (2019-12-01)

Overlap between adverse events (AEs) and serious adverse events (SAEs): a case study of a phase III cancer clinical trial
by: Elizabeth C. James, et al.
Published: (2020-09-01)

What should we report? Lessons learnt from the development and implementation of serious adverse event reporting procedures in non-pharmacological trials in palliative care
by: Lesley Dunleavy, et al.
Published: (2021-01-01)

Assessing the risk-benefit profile of ramucirumab in patients with advanced solid tumors: A meta-analysis of randomized controlled trials
by: Sophie Marie Anne Effing, et al.
Published: (2020-08-01)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
by: Bin Zhao, et al.
Published: (2018-10-01)

The safety and serious adverse events of approved ALK inhibitors in malignancies: a meta-analysis
by: Hou H, et al.
Published: (2019-05-01)

Identification, collection, and reporting of harms among non-industry-sponsored randomized clinical trials of pharmacologic interventions in the critically ill population: a systematic review
by: Ari Moskowitz, et al.
Published: (2020-07-01)

Magnitude and Impacts of Adverse Events of Injectable Containing Shorter Regimen in Programmatic Management of Multi-Drug Resistant Tuberculosis in Ethiopia: A Retrospective Cohort Study
by: Achalu DL, et al.
Published: (2023-11-01)

Adverse Events of DOACs in Children
by: Alessandra Bosch, et al.
Published: (2022-07-01)

Adverse Event Burden Score—A Versatile Summary Measure for Cancer Clinical Trials
by: Jennifer G. Le-Rademacher, et al.
Published: (2020-11-01)

Adverse Events as End Points: The Need to Account for Both Sides of the Same Coin
by: Felipe Aizpuru
Published: (2017-04-01)

Prevalence and predictors of direct discharge home following hospitalization of patients with serious adverse events managed by the rapid response system in Japan: a multicenter, retrospective, observational study
by: Takashi Hongo, et al.
Published: (2021-01-01)

Risk Factors and Incidence Rates of Self-Reported Short-Term Adverse Events of COVID-19 Vaccine Booster Dose
by: Po-Yu Chen, et al.
Published: (2022-07-01)

Systematic adjudication of myocardial infarction end-points in an international clinical trial
by: Lee Kerry L, et al.
Published: (2001-07-01)

Prevalence rate of spontaneously reported adverse events and determinants of serious adverse events amongst three outpatient care settings in ghana: findings and implications
by: Israel Abebrese Sefah, et al.
Published: (2021-01-01)

Inductive Characterization of ENDS-Associated Adverse Events Among California Young Adults
by: Joshua S. Yang, PhD, MPH, et al.
Published: (2022-12-01)

Toxicity related to standard TB therapy for pulmonary tuberculosis and treatment outcomes in the REMoxTB study according to HIV status
by: Conor D. Tweed, et al.
Published: (2019-08-01)

Toxicity associated with tuberculosis chemotherapy in the REMoxTB study
by: Conor D. Tweed, et al.
Published: (2018-07-01)

The value of organ and tissue biovigilance: a cross-sectional analysis
by: Aurora Navarro, et al.
Published: (2024-02-01)

Identification and Evaluation of Safety Signals of Drugs Currently under Development Using a Limited Data Set
by: B. K. Romanov, et al.
Published: (2019-12-01)

Prediction models for major adverse cardiovascular events after percutaneous coronary intervention: a systematic review
by: Wenqi Deng, et al.
Published: (2024-01-01)

Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study
by: Lee Kerry L, et al.
Published: (2001-07-01)

Association between metabolic syndrome and coronary events in dislipidemic patients from the Cardiology and Cardiac Surgery Institute.
by: Elain Gutierrez Carbonell, et al.
Published: (2011-01-01)

Prognosis of Adverse Outcomes in the Research of Coronary Blood Flow During Echocardiography
by: E. S. Kalinina, et al.
Published: (2023-05-01)

Clinical Study on efficacy of allopurinol in patients with acute coronary syndrome and its functional mechanism
by: Ying Huang, et al.
Published: (2017-09-01)

Yellow Fever Vaccine-Related Neurotropic Disease in Brazil Following Immunization with 17DD
by: Flora de Andrade Gandolfi, et al.
Published: (2023-02-01)

Characterization and preventability of adverse drug events as cause of emergency department visits: a prospective 1-year observational study
by: Ivan Lo Giudice, et al.
Published: (2019-04-01)

The Effect of Total Cholesterol Variability on Clinical Outcomes After Percutaneous Coronary Intervention
by: Yanting Liang, et al.
Published: (2022-02-01)

Current and Future Trends in Game-Based Learning
by: Carlos Vaz de Carvalho
Published: (2014-05-01)

Serious Games Conferences and Events
by: Carlos Vaz de Carvalho
Published: (2014-05-01)

Effect of loading dose of atorvastatin therapy prior to percutaneous coronary intervention in patients with acute coronary syndrome: a meta-analysis of six randomized controlled trials
by: Ma M, et al.
Published: (2019-04-01)

Definitions of serious injury in long-term residential care: a systematic review protocol [version 1; peer review: 2 approved]
by: David Morrissey, et al.
Published: (2023-11-01)

The SMART Safety: An empirical dataset for evidence synthesis of adverse events
by: Shiqi Fan, et al.
Published: (2023-12-01)

Stride Length Predicts Adverse Clinical Events in Older Adults: A Systematic Review and Meta-Analysis
by: Ibadete Bytyçi, et al.
Published: (2021-06-01)

A Single Center Analysis of Advanced Non-small Cell Lung Cancer Patients Treated with Immunotherapy in Real-world Practice
by: Yanxia LIU, et al.
Published: (2019-11-01)

Severe and fatal adverse events of immune checkpoint inhibitor combination therapy in patients with metastatic renal cell carcinoma: a systematic review and meta-analysis
by: Yao-Ning Feng, et al.
Published: (2023-06-01)

Safety, efficacy and biomarkers analysis of mesenchymal stromal cells therapy in ARDS: a systematic review and meta-analysis based on phase I and II RCTs
by: Jianbao Wang, et al.
Published: (2022-06-01)

Pharmacovigilance for clinical trials in India: Current practice and areas for reform
by: Ballari Brahmachari, et al.
Published: (2011-01-01)

Development and validation of a clinical predictive model for 1-year prognosis in coronary heart disease patients combine with acute heart failure
by: Xiyi Huang, et al.
Published: (2022-10-01)